Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41956163.
- Also identified by DOI 10.1016/j.ijrobp.2026.03.048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Definitive stereotactic body radiation therapy (SBRT) for inoperable pancreatic ductal adenocarcinoma (PDAC) is often delivered with a non-ablative dose to gross tumor alone despite high rates of locoregional failure (LRF). The purpose of this study was to characterize patterns of failure after definitive ablative SBRT and evaluate the impact of clinical targe volume (CTV) design. We performed a retrospective cohort study of non-metastatic PDAC treated with definitive ablative SBRT on a 0.35 Tesla MR-Linac between 2018-2024. Patients who had surgery were excluded. The median prescribed GTV and CTV doses were 50 Gy and 33 Gy in 5 fractions, respectively. CTV coverage evolved from no CTV or limited perivascular coverage to larger anatomically derived volumes eventually including the "triangle volume". The first diagnostic scan showing LRF was registered to the simulation scan on which the recurrence was contoured. LRFs were classified as in-field, marginal, or out-of-field. Among 121 consecutive patients, 87.6% received induction chemotherapy and 92.6% were treated with a CTV. Median follow-up after SBRT was 12.0 months. LRF occurred in 17 patients (14.0%) at a median of 14.3 months and no LRF was observed in patients treated to the "triangle volume". In-field failures were rare (2.5%) as were marginal (6.6%) and out-of-field (5.0%) failures. LRF involved the primary tumor (n=5; 29.4%), para-aortic lymph nodes (n=4; 23.5%), porta hepatis (n=4 23.5%), superior mesenteric artery (n=3; 17.6%), or celiac artery (n=1; 5.9%). Larger CTV size was associated with a non-statistically significant increase in acute grade 1-2 nausea. This is the first study to characterize patterns of LRF following induction chemotherapy and definitive ablative SBRT for inoperable PDAC. Our findings suggest that routine use of an anatomically derived CTV should be considered including the "triangle volume".